Research Topics
| Jasmina I IvanovaSummaryAffiliation: Analysis Group Country: USA Publications
|
Detail Information
Publications
Duloxetine use in chronic low back pain: treatment patterns and costsJasmina I Ivanova
Analysis Group, Inc, New York, NY 10020, USA
Pharmacoeconomics 30:595-609. 2012..Little is known about the real-world treatment patterns and costs of patients with chronic low back pain (CLBP) who are treated with duloxetine compared with those receiving other non-surgical treatments...- Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthmaJasmina I Ivanova
Analysis Group, Inc, New York, NY 10020, USA
J Allergy Clin Immunol 129:1229-35. 2012..Health care costs increase in patients with more severe asthma, but the effect of asthma exacerbations on costs among patients with more severe asthma has not been quantified... - Impact of medication adherence to disease-modifying drugs on severe relapse, and direct and indirect costs among employees with multiple sclerosis in the USJ I Ivanova
Analysis Group, Inc, New York, NY, USA
J Med Econ 15:601-9. 2012..To compare rates of severe relapse and total direct and indirect costs over a 2-year period between US-based employees with multiple sclerosis (MS) who were adherent and non-adherent to disease-modifying drugs (DMDs)... 
Cost of post-traumatic stress disorder vs major depressive disorder among patients covered by medicaid or private insuranceJasmina I Ivanova
Analysis Group, Inc, New York, USA
Am J Manag Care 17:e314-23. 2011..To compare healthcare costs and resource utilization among patients with post-traumatic stress disorder (PTSD) vs control subjects with major depressive disorder (MDD) in populations covered by Medicaid or private insurance...- Real-world practice patterns, health-care utilization, and costs in patients with low back pain: the long road to guideline-concordant careJasmina I Ivanova
Analysis Group, Inc, New York, NY 10020, USA
Spine J 11:622-32. 2011..Treatment guidelines suggest that most acute low back pain (LBP) episodes substantially improve within a few weeks and that immediate use of imaging and aggressive therapies should be avoided... - Physicians' decisions to prescribe antidepressant therapy in older patients with depression in a US managed care planJasmina I Ivanova
Analysis Group, Inc, New York, New York 10020, USA
Drugs Aging 28:51-62. 2011..Published studies indicate that depression in older adults is severely under-recognized and under-treated... - Direct and indirect costs of employees with treatment-resistant and non-treatment-resistant major depressive disorderJasmina I Ivanova
Analysis Group, Inc, New York, NY 10020, USA
Curr Med Res Opin 26:2475-84. 2010..The objective of this study was to assess direct healthcare costs and indirect (disability and medical-related absenteeism) costs associated with TRD compared with non-treatment-resistant major depressive disorder (MDD)... - Adherence to inhaled corticosteroid use and local adverse events in persistent asthmaJasmina I Ivanova
Analysis Group Inc, New York, NY 10020, USA
Am J Manag Care 14:801-9. 2008.... - Direct and indirect costs associated with epileptic partial onset seizures among the privately insured in the United StatesJasmina I Ivanova
Analysis Group, Inc, New York City, New York, USA
Epilepsia 51:838-44. 2010..Compare annual direct and indirect costs between privately insured U.S. patients with epileptic partial onset seizures (POS) and matched controls... - The cost of disability and medically related absenteeism among employees with multiple sclerosis in the USJasmina I Ivanova
Analysis Group, Inc, New York, New York, USA
Pharmacoeconomics 27:681-91. 2009..0001). MS is a chronic and debilitating disease that poses a substantial employer burden in terms of medically related absenteeism and disability costs. Indirect costs of employees with MS were >4 times those of employee controls... - Economic burden of epilepsy among the privately insured in the USJasmina I Ivanova
Analysis Group, Inc, New York, NY 10020, USA
Pharmacoeconomics 28:675-85. 2010..0001), with a difference of $US8257. Conclusions: Epilepsy was associated with significant economic burden. The excess direct costs in patients with epilepsy are underestimated when only epilepsy-related costs are considered... - Descriptive analysis of Medicaid patients with postherpetic neuralgia treated with lidocaine patch 5%Noam Y Kirson
Analysis Group, Inc, Boston, MA 02199, USA
J Med Econ 13:472-81. 2010..Repeat comparison for the subset of patients treated in long-term care (LTC) settings... - Economic impact of multiple sclerosis disease-modifying drugs in an employed population: direct and indirect costsHoward G Birnbaum
Analysis Group, Inc, Boston, MA, USA
Curr Med Res Opin 25:869-77. 2009..The study objective is to compare the annual total medical and indirect costs of newly treated and untreated employees with multiple sclerosis (MS)... - Excess costs associated with patients with chronic thromboembolic pulmonary hypertension in a US privately insured populationNoam Y Kirson
Analysis Group, Inc, Boston, MA, USA
Appl Health Econ Health Policy 9:377-87. 2011..Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare and potentially fatal disease. Little is known about the economic burden associated with CTEPH patients in the US... - Excess costs associated with patients with pulmonary arterial hypertension in a US privately insured populationNoam Y Kirson
Analysis Group, Inc, Boston, MA, USA
Appl Health Econ Health Policy 9:293-303. 2011..Pulmonary arterial hypertension (PAH) is a rare but fatal disease. Little is known about the economic burden associated with PAH patients in the US... - Comparing healthcare costs of Medicaid patients with postherpetic neuralgia (PHN) treated with lidocaine patch 5% versus gabapentin or pregabalinNoam Y Kirson
Analysis Group, Inc, Boston, MA 02199, USA
J Med Econ 13:482-91. 2010..To compare healthcare resource utilization and costs of postherpetic neuralgia (PHN) patients initiating lidocaine patch 5% (lidocaine patch) or oral gabapentin/pregabalin... - Real-world role of tricyclic antidepressants in the treatment of fibromyalgiaCatherine Reed
Lilly Research Centre, Windlesham, Surrey, UK
Pain Pract 12:533-40. 2012..To examine the real-world role of tricyclic antidepressants (TCAs) in fibromyalgia (FM) treatment... - Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapiesEric Q Wu
Analysis Group, Inc, Boston, MA 02199, USA
J Manag Care Pharm 13:561-9. 2007.... - Prevalence of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the United StatesNoam Y Kirson
Analysis Group, Inc, Boston, MA, USA
Curr Med Res Opin 27:1763-8. 2011..The prevalence of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) in the US is largely unknown. Prior research has estimated PAH prevalence in Europe at ∼15-52 per million...